Agilent Technologies Could Be 23% Undervalued After Earnings Beat and Guidance Raise

Earnings
โดย Simply Wall St·Read original
Summary · why it matters

Agilent Technologies reported quarterly results that exceeded analyst expectations on both revenue and earnings, and the company raised its full-year guidance. The stock is trading at $127.06, while the most followed analyst narrative points to a fair value of $161, implying a potential undervaluation of about 23%. Strategic investments in higher-margin recurring revenue streams such as consumables, software, services, and digital platforms are gaining traction, with CrossLab and services delivering consistent mid-single-digit growth. However, pressure points remain, including elevated tariff-related costs and potential further weakening in academic and government funding.

Impact on stocks 1

Biotech & Genomic Medicine · 1 stocks
Agilent Technologies Inc
A
▲ PositiveCapitalrelevance

Agilent reported earnings and revenue beat and raised full-year guidance, with analyst pointing to 23% undervaluation.